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Summary 
Bcr/Abl is a chimeric oncogene that can cause both acute and chronic human leukemias. Bcr/ 
Abl-encoded proteins exhibit elevated kinase activity compared to c-Abl, but the mechanisms 
of transformation are largely unknown. Some of the biological effects of Bcr/Abl overlap with 
those of hematopoietic cytokines, particularly interleukin 3  (IL-3). Such effects include mito- 
genesis,  enhanced survival, and enhanced basophilic differentiation. Therefore, it has been sug- 
gested that p210Bcr/Abl and the IL-3 receptor may activate some common signal transduction 
pathways. An important pathway for IL-3 signaling involves activation of the Janus family ki- 
nases  OAKs) and subsequent tyrosyl phosphorylation of STAT proteins (signal transducers and 
activators of transcription). This pathway directly links growth factor receptors to gene tran- 
scription. We analyzed JAK activation, STAT protein phosphorylation, and the formation of 
specific DNA-binding complexes containing STAT proteins, in a series of leukemia cell lines 
transformed by Bcr/Abl or other oncogenes. We also examined these events in cell lines trans- 
formed by a temperature sensitive  (ts) mutant  of Bcr/Abl, where the kinase  activity of Abl 
could be regulated.  STAT1  and STAT5 were found to be constitutively phosphorylated in 
32D, Ba/F3, and TF-1 cells transformed by Bcr/Abl, but not in the untransformed parental cell 
lines in the absence of IL-3. Phosphorylation of STAT1 and STAT5 was also observed in the 
human leukemia cell lines K562 and BV173, which express the Bcr/Abl oncogene, but not in 
several Bcr/Abl-negative leukemia cell lines. Phosphorylation of STAT1 and STAT5 was di- 
recdy due to the tyrosine kinase activity of Bcr/Abl since it could be activated or deactivated 
by temperature shifting of cells  expressing the  Bcr/Abl  ts  mutant.  DNA-STAT  complexes 
were detected in all Bcr/Abl-transformed cell lines and they were supershifted by antibodies 
against  STAT1 and STAT5. DNA-STAT complexes in 32Dp210Bcr/Abl cells were similar, 
but not identical, to those formed after IL-3 stimulation. It is interesting to note that JAK ki- 
nases (JAK1, JAK2, JAK3, and Tyk2) were not consistently activated in Bcr/Abl-positive cells. 
These data suggest that STATs can be activated directly by Bcr/Abl, possibly bypassing JAK 
family kinase activation. Overall, our results suggest a novel mechanism that could contribute 
to some of the major biological effects of Bcr/Abl transformation. 
B  cr/Abl is a chimeric oncoprotein generated by a recip- 
rocal  translocation  between  chromosomes  9  and  22 
and implicated in the pathogenesis of Philadelphia chromo- 
some positive (Ph+) t human leukemias (1, 2).  Fusion pro- 
teins of either 210 (p210) or 185 kD  (p185) are generated 
and  are  associated  with  chronic  myelogenous  leukemia 
(CML) or acute lymphocytic leukemia, respectively. 
1Abbreviations used in  this paper: CML, chronic myelogenous leukemia; 
FBS, fetal  bovine serum; IRF-1, interferon-responsive  factor 1; JAK, Ja- 
nus kinase; Ph  §  Philadelphia chromosome;  STAT, signal transducer and 
activator of  transcription; ts, temperature  sensitive. 
Both p210 and p185 Bcr/Abl proteins exhibit increased 
tyrosine kinase  activity and transforming properties com- 
pared with the normal c-Abl protein (3,  4).  p210Bcr/Abl 
can cause a CML-like syndrome in mice in vivo (5), con- 
verts  IL-3-  and  GM-CSF-dependent  hematopoietic  cell 
lines to factor independence, and transforms immature he- 
matopoietic cells in vitro (6-9). The elevated tyrosine ki- 
nase activity is essential  for its transforming activity, but the 
mechanisms  involved in  p210Bcr/Abl-mediated  transfor- 
mation are unknown. Some biological effects ofp210Bcr/ 
Abl are known to overlap with those of IL-3. For example, 
chronic administration  of IL-3  or unregulated  IL-3  gene 
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similar to that seen in CML (10-12).  Further, p210Bcr/Abl 
expression and IL-3 stimulation induce tyrosine phosphor- 
ylation of an  overlapping set  of membrane  and  cytoplas- 
mic  proteins,  suggesting  that  similar  biological  effects  of 
p210Bcr/Abl and IL-3 may in part result from activation of 
common signal  transduction  pathways  (13).  For  instance, 
Shc, Vav, Fes,  Paxillin,  and SHPTP2 are known to be ty- 
rosyl  phosphorylated  by  both  IL-3  and  p210Bcr/Abl  in 
myeloid  cells  (14-18).  However,  the  role  of these  phos- 
phoproteins  in  both  IL-3-mediated mitogenesis  and  Bcr/ 
Abl-mediated transformation is still undetermined. 
Recently, a signal transduction pathway that involves Ja- 
nus  kinases  OAKs) and  signal transducers  and  activators of 
transcription  (STATs)  has been shown  to be  regulated  by 
several hematopoietic cytokine receptors,  including IL-3R 
and GM-CSFK (for reviews see references 19 and 20). The 
JAK family  members  0AK1, JAK2, JAK3,  and  Tyk2)  are 
~130-kD  cytosohc  tyrosine  kinases  that  are  phosphory- 
lated  and  activated  in  response  to  cytokine  stimulation. 
JAK activation leads to phosphorylation of STAT proteins 
(21-23)  which  then  dimerize,  translocate  to  the  nucleus, 
and bind specific promoter  elements  to regulate  gene  ex- 
pression. STAT proteins, therefore, function as a direct link 
between growth factor receptors and the nucleus (24). The 
STAT family includes at least six members that can be acti- 
vated by one or more JAK family kinase in response to spe- 
cific  cytokines.  Each  cytokine  receptor  tends  to  signal 
through a subset  of STATs,  typically leading to the  phos- 
phorylation of one to three different STATs. For example, 
IL-3  and  GM-CSF  induce  tyrosine  phosphorylation  of 
STAT5  (25),  STAT6  (26),  and  STAT1  (27),  predomi- 
handy through activation of  JAK2 (28). 
Since IL-3 stimulation and Bcr/Abl expression have sim- 
ilar effects in hematopoietic cells and result in tyrosyl phos- 
phorylation of common substrates,  we investigated the po- 
tential  involvement  of the  JAK-STAT  pathway  in  Bcr/ 
Abl-mediated  transformation.  It  is  interesting  that  we 
found that Bcr/Abl induces both the tyrosine phosphoryla- 
tion of selected STAT proteins and the formation of STAT- 
containing  DNA-binding  complexes.  Despite  leading  to 
STAT  phosphorylation,  Bcr/Abl  did  not  significantly  or 
consistently increase phosphorylation of  JAKs. 
Material and Methods 
Cells and Cell Culture.  The  32Dc13  cell  line  (29) was  ob- 
tained  from Joel  Greenberger  (University  of Pittsburgh,  Pitts- 
burgh,  PA).  The Ba/F-3 cell  line  (30) was  obtained from Alan 
D'Andrea (Dana-Farber  Cancer Institute).  The BV173 cell line 
(31)  was  obtained  from  Bruno  Calabretta  (Jefferson  Medical 
School, PMladelphia,  PA).  The KL and NALM6 cell lines  (32, 
33) were obtained from John Gribben  (Dana-Farber Cancer In- 
stitute).  TF-1  (34),  K562  (35),  HL60 (36), and U937  (37) cells 
were  obtaaned  from  the  American  Type  Culture  Collection 
(R.ookville,  MD).  K562,  HL-60,  and  U937  were  grown  in 
R_PMI 1640 medium (Mediatech,  Washington, D.C.) containing 
10% fetal bovine serum (FBS). LL-3-dependent 32Dcl 3 and Ba/ 
F-3 cells were  cultured  in  RPMI  1640  medium  supplemented 
with  10%  FBS  and  10%  WEHI-3B  conditioned  medium  as 
source  of murine  IL-3.  GM-CSF-dependent  TF-1  cells were 
cultured in RPMI 1640 supplemented with 10% FBS and human 
1 ng/ml GM-CSF (Genetics  Institute,  Cambridge, MA). 
pGDp210 (5), a p210Bcr/Abl expression  vector, was obtained 
from George Daley and David Baltimore (Massachusetts Institute 
of Technology, Cambridge, MA). The p210Bcr/Abl temperature 
sensitive  (ts) mutant (p210Bcr/AblTS-1) was generated by intro- 
ducing two point mutations in the tyrosine kinase domain of Abl 
as described  (38); it was subsequently  cloned into pGD. Sublines 
expressing  pGDp210Bcr/Abl  or  pGDp210  Bcr/AblTS-I  were 
generated  by  transfection  of  the  corresponding  vector  into 
32Dc13, Ba/F-3, or TF-1 cells by electroporation, as previously 
described  (5) using a Gene Pulser (Bio-Rad, Kichmond, CA) and 
selecting  for G418-resistant  cell lines. All  cell  lines  transfected 
with  pGDp210  Bcr/Abl  became  factor independent  and  were 
thereafter  cultured in R.PMI 1640 containing 10% FBS. 32D cells 
expressing  p210Bcr/AblTS-1  were IL-3 dependent when main- 
tained  at  the  nonpermissive  temperature  (39~  and  therefore 
were cultured  in  KPMI supplemented  with  10% FBS and  10% 
WEHI-3B conditioned  medium as a source of 1L-3. 
Cytokine Starvation and Stimulation.  Before  lysis, the  |~ctor- 
dependent cell lines 32D, Ba/F-3, and TF-1  cells were cytokme 
deprived for 18 h  and then stimulated  for 15  rain with  control 
buffer,  10  ng/ml  murine  IL-3  (Upstate  Biotechnologies,  Inc., 
Lake  Placid,  NY),  10  ng/ml  human  GM-CSF  (Genetics  Insti- 
tute),  or  100  U/ml  murine  IFN-r  (Sibmla Chemical  Co.,  St. 
Louis,  MO).  The  32Dp210Bcr/AblTS-1  cell  line  was cytokine 
deprived for 18 h at  the nonperrmssive  temperature  (39~  and 
then shifted for various lengths  of time to the pemfissive  temper- 
ature  (33~  The  K562,  BV173,  HL-60,  U937,  KL,  NALM6 
and  the  p210Bcr/Abl  transfected  cell  lines  were  maintained  in 
R.PMI 1640 medium supplemented with 10% FBS. 
Antibodies.  An antiphospho-STAT1 antibody was raised to a 
mouse  STAT1  peptide,  containing  amino  acids  694-705  in 
which  the  tyrosine residue  in  position  71)1 was phosphorylated 
(39). The antiphosphotyrosine antibody (4G10)  was a gift from 
B.  Druker  (Oregon Health  Science University,  Portland,  OR). 
The  anti-STAT1  p91  COOH  tenninus  and  anti-STAT5  anti- 
bodies used for supershift  experiments were a ~ft from C. Schin- 
diet (Columbia University,  New York) and from J. Rosen (Baylor 
College of Medicine, Houston, TX), respectively.  The anti-JAK3 
antibody was a gift fi'om J. lhle (St. Jude's Childrens Cancer Re- 
search Institute, Memphis,  TN). Antibodies  against STATla +  13, 
STAT3, STAT4, STATt, and Tyk2 were from Santa Cruz Bio- 
technology (Santa Cruz, CA); anti-STAT5 was from Transduc- 
tion  Lab  (Lexington,  KY);  and  antibodies  to JAKI  and JAK2 
were from Upstate  Biotechnologies, Inc. 
Immunoblottingandlmmunoprecipitation.  ('ells  were  lysed  in 
1% NP-40, 50 mM Hepes,  0.5 mM EGTA, and 10% glycerol ly- 
sis solution containing  1 mM PMSF, 20 la.g/ml aprotinin, and 1 mM 
sodium Na3VO  4 at 10  s cells/ml.  Lysates were adjusted  to contain 
equal  amounts  of total  protein,  using  the  Bradford  assay (Bio- 
lLad),  and were either boiled for 5 min in  an  equal  volume of 
SDS sample  buffer before loading on a SDS-polyacrylamide gel 
or were used for immunoprecipitation.  50-100 ~1 of each lysate 
was  incubated  with  51)  la,  l of the  antiphosphotyrosine antibody 
4(;10 coupled to protein A-Sepharose beads for 3 h at 4~  and 
then  washed  three  times  with  lysis solution.  For JAK  immuno- 
precipitation,  cells were lysed in  1% Brij  96,  50 mM Tris,  15(I 
mM NaC1, and 5 mM EI)TA lysis solution  containing 5 mM leu- 
peptin,  10  Ixg/ml aprotinin,  1 mM  Na~VO4,  1 mM  PMSF,  111 
812  Bcr/Abl Activates STAT Proteins mM NaF, and 100 mg/ml trypsin inhibitor at l0  s cells/ml.  After 
incubation  with  the  JAK  antibody  and  protein  A-Sepharose 
beads  for  3  h  at  4~  immunoprecipitates  were  washed  three 
times  with  1:10  diluted  lysis buffer.  Proteins were separated  by 
7.5% SDS-PAGE and electrophoretically tramferred to nitrocel- 
lulose  (Schleicher  &  Schuell,  Inc.,  Keene,  NH).  Western  blots 
were  performed as described  (16).  lmmunoreactive bands were 
visualized with the enhanced chemiluminescence (ECL) Western 
blotting system (Amersham Corp., Arlington Heights,  IL) or with 
the alkaline phosphatase  method as described (40). 
Nuclear Extracts.  Cells were plated on ice,  washed once with 
cold PBS,  resuspended,  and incubated on ice for 5 min in 5 ml 
hypotonic buffer (10 mM Tris, pH 7.4, 10 mM NaCI, and 6 mM 
MgClz).  Cells  were then pelleted,  resuspended in 0.8 ml hypo- 
tonic buffer containing 1 mM 2-ME, 10 mg/rrd PMSF, and 1 mM 
Na3VO  4 and  disrupted  by shearing  in  a  Dounce  homogenizer 
(type B pesde,  40 strokes;  Kontes Glass Co., Vineland,  NJ).  Nu- 
clei  were collected by a  10-s centrifugation at  12,000 g, washed 
once  with  hypotonic buffer,  resuspended  in  3  vol of high  salt 
buffer (20 mM Hepes, pH 7.9, 420 mM NaC1, 25% glycerol, 1.5 
mM  MgCI2,  0.2  mM  EDTA,  1 mM  13ME, 1 mM  PMSF,  and 
1 mM Na3VO4) and mixed at 4~  for 30 min.  After centrifuga- 
tion at 12,000 g for 3 rain at 4~  supematants containing the nu- 
clear proteins were recovered. 
Electrophoretic Mobility Shift Assay.  A DNA binding assay was 
performed as described (39),  using a 32P-labeled oligonucleotide 
5'-AGCCTGAT'I~CCCCGAAATGACGGC-3', derived  from 
the interferon-responsive  1 (IILF-1)  promoter sequence.  To de- 
tect the presence of specific  proteins in the DNA protein com- 
plexes,  0.5  ~1  of control antisera,  anti-STAT1,  or anti-STAT5 
was  added  to  the  reaction  for  30  min  at  4~  before  loading. 
DNA-protein complexes were separated  by Tris-borate-EDTA/ 
5% PAGE and visualized by autoradiography. 
Results 
Tyrosyl Phosphorylation  of STAT  Proteins in  Bcr/Abl-posi- 
rive Cell Lines.  To  analyze  STAT  protein  phosphoryla- 
tion,  we used an antiserum  generated to a phosphopeptide 
containing  the  tyrosine  phosphorylation  site  of STAT1, 
Tyr 701  (39). We have previously shown that this antibody 
specifically recognizes the tyrosine-phosphorylated forms of 
STAT1  and  STAT5  (Frank,  D.A.,  unpublished  observa- 
tions).  STAT  protein  phosphorylation  was  examined  in 
three different IL-3- or GM-CSF-qependent hematopoietic 
cell  lines,  and  in  p210Bcr/Abl-transformed  subclones  of 
each  cell  line.  As  shown  in  Fig.  1  A,  the  antiphospho- 
STAT  antibody  detected  91-95-kD  tyrosyl-phosphory- 
lated  STAT proteins  in  nontransformed  Ba/F3,  32D,  and 
TF-I  cells after stimulation  with  IL-3 or GM-CSF,  (lanes 
4-6), but not in the absence of factor stimulation (lanes  1-3). 
In contrast,  in the Bcr/Abl-transformed cell lines,  tyrosyl- 
phosphorylated  STAT  proteins  were  detected  in  the  ab- 
sence  of factor stimulation  (lanes  7-9).  It is  interesting  to 
note  that  the  addition  of IL-3 or GM-CSF  to  any of the 
three  Bcr/Abl-transformed  cell  lines,  did  not  further  in- 
crease  reactivity  with  the  antiphospho-STAT1  antibody 
(data not shown). As shown in Fig. 1 B, factor-independent 
STAT tyrosyl phosphorylation correlated with  the expres- 
sion  of p210Bcr/Abl.  STAT  protein  phosphorylation  was 
Figure 1.  (A) Tyrosyl phosphorylauon of STAT proteins in p2IOBcr/ 
Abl-transfected cells. Untransfected cells from 32D, Ba/F3, and TF-1 cell 
lines, were growth factor deprived for 18 h and then sfmulated with con- 
trol buffer (lanes I-3) or growth factor: 10 ng/ml murine recombinant 
IL-3 (BaF/3 and 32D cells, lanes 4-5) or 10 ng/ml human recombinant 
GM-CSF (TFI cells, lane 6) for 15 rain, before lysis. All Bcr/Abl-trans- 
fected sublines (lanes 7-9) did not require growth factor for survwal or 
proliferation and were grown in R.PMI with 10~  FBS before lysis. Cellu- 
lar proteins were separated by SDS-PAGE, transferred to nitrocellulose, 
and probed with antiphospho-STATl antiserum. (B) c-Abl and p210Bcr/ 
Abl expression. The nitrocellulose membrane in A was stopped and re- 
probed with an antibody ag',unst  c-Abl. Control levels ofc-Abl in the un- 
transfected cells (lanes 1-6) and of c-Abl and p210Bcr/Abl in the trans- 
fected sublines (lanes 7-9) are shown. 
also  analyzed  in  two  human  Ph  §  leukemia-derived  cell 
lines, K562 and BV173, and compared with two Ph- mye- 
loid  leukemia  cell  lines,  HL-60  and  U937,  and  two  Ph- 
lymphoid leukemia cell lines,  ILL and Nalm6. As shown in 
Fig.  2,  the  antiphospho-STAT1  antiserum  recognized ty- 
rosyl-phosphorylated STAT proteins  only in  the  Ph +  cell 
lines,  suggesting  that  constitutive  tyrosyl phosphorylation 
of STAT  proteins  is  an  event  specifically  associated  with 
Bcr/Abl transformation. 
Tyrosyl  Phosphorylation  of STA T  Proteins Is Dependent  on 
Bcr/Abl Tyrosine Kinase Activity.  To  further  analyze  the 
relation between Bcr/Abl expression and STAT protein ty- 
rosyl phosphorylation,  we  examined  STAT protein  phos- 
phorylation in 32D cells transfected with a ts mutant of the 
p210Bcr/Abl  kinase  (p210TS-1).  The  Bcr/Abl  ts kinase  is 
minimally active at 39~  (nonpermissive  temperature)  and 
has increased activity at 33~  (permissive temperature)  (38). 
In parallel with the Bcr/Abl kinase activation, 32Dp210TS-1 
cells  are  completely  IL-3 dependent  at  the  nonpermissive 
temperature and IL-3-independent for survival (but not for 
proliferation)  at  the  permissive  temperature  (38).  In  ab- 
813  Carlesso et al. Figure 2.  Tyrosyl  phosphorylation  of STAT proteins in Ph  + cell lines. 
Cells were grown in KPMI with 10% FCS before lysis. Cellular proteins 
were separated by SDS-PAGE, transferred to nitrocellulose, and probed 
with antiphospho-STAT1 antiserum as in Fig. 1 A. (Lane 1) IL-3-stimu- 
lated 32D cells as positive control. The ,"~70-kD bands observed in lanes 6 
and  7 were  not  recognized by any specific antibody against known 
STATs. 
sence  of growth factor,  tyrosyt phosphorylation of cellular 
proteins increases  rapidly after shifting 32Dp210TS-1  cells 
to  the  permissive  temperature  (Fig.  3  A),  consistent  with 
previous studies  (38,  41).  No detectable  effects on cellular 
protein  tyrosine  phosphorylation  were  observed  after  a 
similar  temperature  shift  in  control  32D  cells  transfected 
with  the  vector pGD  alone  (38).  In 32Dp210TS-1  trans- 
fectants,  tyrosyl phosphorylation  of STAT proteins  corre- 
lated with p210Bcr/Abl kinase activation (Fig. 3  B).  STAT 
proteins  were  tyrosyl  phosphorylated  in  the  absence  of 
growth factor as early as  15 rain after the temperature  shift 
(Fig. 3  B, lane  3) and the level of phosphorylation contin- 
ued to increase over time  (Fig. 3  B, lanes  4-6; Fig. 4, lanes 
7  and  8)  reaching a  plateau  at N6-12  h.  (Fig.  3  C  shows 
comparable levels of  p210Bcr/AblTS-1 protein in the sam- 
ples).  Phosphorylation of STAT proteins was not detected 
at the  nonpermissive  temperature  in  the  absence  of factor 
stimulation  (Fig.  3  B,  lane  2;  Fig.  4,  lane  6),  although  it 
could be efficiently induced by IL-3 addition  (Fig.  4, lane 
4).  Phosphorylation of STAT proteins was rapidly reduced 
(within  15 min)  as the cells  were shifted from the permis- 
sive to the nonpermissive  temperature  (Fig.  4, lanes  9  and 
10).  These  results  indicate  that tyrosyl phosphorylation  of 
STAT proteins is dependent  on the tyrosine kinase activity 
of Bcr/Abl. 
However,  one possible  explanation for the observed ty- 
rosyl phosphorylation of STAT proteins  in p210Bcr/Abl- 
expressing  cells  is  autocrine  secretion  of  IL-3  or  other 
growth factors,  a  phenomenon  that  has  been  observed  in 
some  cell  lines  transformed  by Bcr/Abl  (42),  but  not  in 
others  (43).  Two observations suggest that the phosphory- 
lation of STAT-related proteins in these Bcr/Abl-express- 
ing cells  is not likely due to autocrine  secretion  of growth 
factors after Bcr/Abl activation. First, increased phosphory- 
lation  of STAT  proteins  in  32Dp210TS-1  was  observed 
very  rapidly  after  temperature  shift  (<15  min;  Fig.  3  B, 
lane  3).  Second, after a temperature  shift from the permis- 
sive to the nonpermissive temperature, the phosphorylation 
Figure 3.  (A) Levels ofphosphotyrosine in cellular proteins in cells ex- 
pressing p210Bcr/AblTS. 32Dp210Bcr/Ab1TS-1 cells growing at 39~ 
were growth factor deprived for 18 h (lane 2) and shifted to 33~  for 15 
and 30 rain, 1 and 3 h before lysis (lanes 3-6). Untransfected 32D cells, 
used as control, were factor deprived for 18 h and stimulated with IL-3 
(10 ng/ml for 15 rain), (lane I) before lysis. Lysates  were treated as in Fig. 
1 A and immunoblotted with an antiphosphotyrosine  antibody. (B) Levels 
of phosphotyrosine in  STAT proteins from cells expressing p210Bcr/ 
AblTS-I. Lysates  from the same experiment as in A were probed with the 
antiphospho-STAT1 antiserum. (C) p210Bcr/AblTS-1 expression in the 
transfected cells. The nitrocellulose membrane from/3 was stripped and 
reprobed with an anti c-Abl antibody. 
of STAT proteins declined within  15 rain  (Fig.  4, lane  9). 
Such very rapid changes in STAT protein phosphorylation 
with the temperature  shift are not consistent with an auto- 
crine response. 
To address more directly the possibility of an autocrine 
mechanism,  supernatants  from 32Dp210  or 32Dp210TS-1 
cells  grown  at  the  permissive  temperature  were  tested  for 
the  presence  of factors  that  could  induce  either  STAT 
phosphorylation or S-phase entry in growth factor-deprived 
32D  cells.  Cells  were  washed,  incubated  either  at  37~ 
(32Dp210)  or 33~  (32Dp210TS-1), and supernatants were 
collected after 6,  12, and 24 h  of incubation.  The supema- 
tants, undiluted or diluted (1 : 2, 1 : 4) failed to sustain survival 
or induce  proliferation  of factor-deprived  32D  cells  (data 
not shown). These supematants also failed to induce tyrosyl 
phosphorylation  of  STAT  proteins  in  either  cytokine- 
deprived 32D or 32Dp210TS-1 cells (Fig. 4, lanes 3 and 5). 
These results  demonstrate that in these cell lines,  p210Bcr/ 
Abl  does  not  induce  secretion  of a  cytokine  in  sufficient 
amounts to induce STAT phosphorylation in an autocrine 
manner. 
Identification of the  STAT  Proteins Phosphorylated in  Bcr/ 
Abl-positive  Cell Lines.  To further characterize  STAT pro- 
teins  phosphorylated in Bcr/Abl-positive  cells,  cell  lysates 
814  Bcr/Abl Activates STAT Proteins Figure 4.  Levels  ofphosphotyrosine in STAT proteins in cells express- 
ing  p210Bcr/AblTS-1.  32Dp210Bcr/AblTS-1  cells growing  at  39~ 
were growth factor deprived for 18 h (lane 6) and shifted to 33~  for 3 
and 6 h (lanes 7 and 8) before lysis. 32Dp210Bcr/AblTS-1 cells growing 
at 33~  in the absence of growth factor for 6 h were shifted back to 39~ 
for 15 and 30 rain (lanes 9 and 10) before lysis. 32p210Bcr/AblTS-1 cells 
(at 39~  and 32D parental cells were factor deprived for 18 h and stimu- 
lated with 10 ng/ml IL-3 for 15 min (lanes 2 and 4) or with the superna- 
tants of 32Dp210 cells and of 32Dp210TS-1  cells at 33~  respectively 
(lanes 3 and 5), before lysis. Lysates  were treated as in Fig. 1 A and probed 
with the antipbospho-STAT1 antiserum. 
were  immunoprecipitated  with  antiphosphotyrosine  anti- 
body 4G10,  followed by Western blotting  with  antibodies 
against STAT1,  STAT3,  STAT4,  STAT5,  and STAT6.  As 
shown  in  Fig.  5  A,  anti-STAT1  antibody  detected  two 
proteins, p91 and p84, in antiphosphotyrosine  immunopre- 
cipitates  from  32D  cells  stimulated  with  IL-3,  32Dp210, 
and BV173  cells  (lanes 2,  3,  and  5).  In K562  cells,  a single 
band  of ~90  kD  was  detected  (Fig.  5  A,  lane  4).  Anti- 
STAT5  antibody detected a 93-kD protein in IL-3-stimu- 
lated  32D  cells,  32Dp210,  K562,  and  BV173  cells  (Fig.  5 
B, lanes 2-5).  In K562  cells,  the STAT5  antibody also de- 
tected a lower molecular weight band of"~91  kD. STAT3, 
STAT4,  and STAT6  antibodies  did not detect any protein 
in any of the antiphosphotyrosine immunoprecipitates  (data 
not shown). 
Overall,  these  data  suggest  that  the  STATs phosphory- 
lated in response  to p210Bcr/Abl  are similar to the  STAT 
proteins phosphorylated by IL-3. However, it is also possi- 
ble  that  other  STAT-related  proteins,  not  yet  character- 
ized, are involved in IL-3 or p210Bcr/Abl signaling. 
JAK  Phosphorylation Is  Not  Consistently  Increased in  Bcr/ 
Abl-transformed  Cell Lines.  To  determine  if phosphoryla- 
tion  of STAT  proteins  in  p210Bcr/Abl-transformed  cells 
was secondary to activation of  JAK family kinases, we analyzed 
tyrosyl  phosphorylation  of the JAK  proteins  in  p210Bcr/ 
Abl--expressing cells. Cell lysates from 32D, 32Dp210,  K562, 
or  BV173  cells  were  analyzed  simultaneously  for  tyrosyl 
phosphorylation  ofJAK1, JAK2,  Tyk2,  and JAK3  and  for 
tyrosyl  phosphorylation  of STAT  proteins.  As  shown  in 
Fig.  6  A,  IL-3  induced  strong  tyrosyl phosphorylation  of 
Figure 5.  STAT1  and STAT5 tyrosyl phosphorylation in p210Bcr/Abl 
cells. 32D cells were growth factor deprived for 18 h and then stimulated 
with control buffer (lane 1) or 10 ng/ml murine recombinant IL-3 (lane 
2) before lysis. 32Dp210, K562, and BV173 cells were grown in RPMI 
with  10% FCS before lysis. Lysates were immunoprecipitated with  the 
antiphosphotyrosine antibody 4G10 and then subjected to Western blot 
analysis with anti-STAT1 (A) and with anti-STAT5 (B) antibodies. 
JAK1  andJAK2  in 32D cells (lanes 2  and  7).  However, ty- 
rosyl phosphorylation  of  JAK1  and JAK2 was not detected 
in 32Dp210  and K562 cell lines (Fig. 6 A, lanes 3,  4,  8, and 
9).  In BV173  cells,  a small amount oftyrosyl phosphoryla- 
tion of  JAK1  was detected  (Fig.  6 A, lane 5) whereas JAK2 
was not phosphorylated  (Fig. 6 A, lane  10).  In K562 cells a 
small  amount  of tyrosyl phosphorylation  of Tyk2 was de- 
tected  (Fig.  6  A,  lane  14).  Phosphorylation  of JAK3  was 
not  observed  in  any  of the  cell  hnes  analyzed  (data  not 
shown).  Approximately  equal  amounts  of JAK1  and JAK2 
protein were detected in all cell lines (Fig. 6  B, lanes  1-10), 
whereas Tyk2 was found to be expressed only in K562 cells 
(Fig.  6  B,  lane  14).  Despite  differences  in  levels  of JAK 
phosphorylation,  comparable amounts of STAT protein ty- 
rosyl  phosphorylation  were  observed  in  factor-stimulated 
32D  cells  and  in  32Dp210,  K562,  and  BV173  cells,  as 
shown in Fig. 6  C. 
It is  interesting  to  note  that  tyrosyl phosphorylation  of 
JAK1  and  JAK2  in  these  p210Bcr/Abl-transformed  cell 
lines could not be induced or augmented by addition oflL-3 
or GM-CSF  (data not shown). 
Overall,  these results show  that,  in  contrast with  STAT 
protein  phosphorylation,  there  is no  consistent  increase  in 
the steady state tyrosyl phosphorylation  of the JAKs in cells 
transformed by p210Bcr/Abl. 
Bcr/Abl  Activates DNA-binding  Activity  Involving STATs. 
After  cytokine-induced  tyrosyl  phosphorylation,  STAT 
proteins  translocate  to the  nucleus  and modulate  gene  ex- 
pression by binding to specific promoter sequences  (19-23). 
To examine Bcr/Abl-transformed  cells for the presence of 
STAT-containing  DNA-binding  complexes,  nuclear  ex- 
tracts were  prepared  from IL-3--deprived and  IL-3--stimu- 
lated  32D  cells,  and  from  32Dp210,  BV173,  K562,  and 
U937  cell hnes.  Proteins in the extracts were examined for 
their ability to bind a sequence  from the  IR.F-1  promoter. 
This  sequence  has  been  shown  previously  to  bind  phos- 
815  Carlesso et al. Figure 6.  JAK kinase phosphorylation in p210Bcr/ 
Abl cells. 32D cells were starved and stmmlated with 
control buffer (lanes 1, 6, and 11), with 10 ng/ml IL-3, 
as a control for JAK1 and JAK2 activation, (lanes 2 
and  7)  or with  100  U/ml  IFN-ct, as a control for 
Tyk2  activation,  (lane 12)  before  lysis. 32Dp210, 
K562, and BVI73  were maintained in  RPMI with 
10% medium before lysis. (A) Lysates  were immuno- 
precipitated with  anti-JAKl (lanes 1-5),  anti-JAK2 
(lanes 6-10),  and  anti-Tyk2  antisera (lanes 11-15) 
and subjected to  Western blot analysis with  an an- 
tiphosphotyrosine antibody.  (B)JAK  protein  levels 
were  determined  using the  respective antisera after 
stripping of the  nitrocellulose membrane in A.  (C) 
Lysates were analyzed for STAT protein phosphory- 
lation using the antiphospho-STAT1 antibody. 
phorylated  STATI,  STAT3,  and  other related  STAT pro- 
teins, and to mediate a STAT-dependent  transcriptional  re- 
sponse  (39,  44).  As shown  in  Fig.  7, A  and  B  (lanes  1 and 
6),  no  DNA-binding  activity could  be detected  in  nuclear 
extracts from IL-3-deprived 32D  cells,  or in the U937  cell 
hne  (which  does not  express Bcr/Abl).  In IL-3-stimulated 
32D  cells  and  in  the  p210Bcr/Abl-transformed  cells,  we 
observed formation of DNA-bindmg complexes. These com- 
plexes  were  specific  for  the  IRF-1  promoter  sequence, 
since they could be competed by the addition of excess un- 
labeled probe  (data  not  shown).  In 32D  cells,  IL-3 stimu- 
lated the formation of a single complex (complex l;  Fig. 7, 
A  and B, lane 2), whereas p210Bcr/Abl  induced the forma- 
tion  of three  distinct  complexes  (Illa,  lllb,  and  IV;  Fig.  7, 
A  and  B,  lane  3).  In K562  cells,  a  single  complex was ob- 
served (II; Fig. 7, A  and  B, lane  4), whereas the complexes 
in BV173  cells were similar to those in 32Dp210  cells (Fig. 
7,  A  and  B,  lane  5).  To  determine  if the  DNA-binding 
complexes  observed  contained  STAT  proteins,  supershift 
experiments  were  carried  out  by  adding  anti-STAT  anti- 
bodies  to  the  binding  reaction.  Antibody  against  STAT1 
(Fig.  7  A)  led  to  the  formation  of supershifted  complexes 
(A)  in  all  samples.  Antibodies  against  STAT5  (Fig.  7  B) 
completely  abohshed  complex  I  in  IL-3-stimulated  32D 
cells (lane  8), complex II in K562 cells (lane  10),  and com- 
plex  llla  in  32Dp210  and  BV173  cells  (lanes  9  and  I2), 
leading  to  formation  of  supershifted  complexes  (A).  In 
32Dp210  and  in BV173  cells,  complexes  IIIb and  IV  (Fig. 
7,  A  and  B,  lanes  9 and  12)  were not supershifted  by anti- 
body  against  either  STAT1  or  STAT5,  or  by a  combina- 
tion  of the  two  antibodies.  The  observation  that  the  anti- 
STAT5 antibody completely supershifts complexes l and II, 
which  also  contain  STAT1,  suggests  that  STAT1-STAT5 
heterodimers  may  be  present  and  more  efficiently  bound 
by anti-STAT5  antibodies. 
In  conclusion,  these  data  suggest  that  specific  DNA- 
binding  activity  of STAT1  and  STAT5  is  induced  in  re- 
sponse to Bcr/Abl. 
Discussion 
Activation of the JAK family kinases, followed by STAT 
protein  phosphorylation,  represents  a  newly  defined  signal 
transduction  pathway  that directly links cytokine  receptors 
to gene  expression  (21-23).  The JAK/STAT  pathway  ap- 
pears to be distinct  and  independent  from the p21ras path- 
way and  is activated by many different  cytokines with  dif- 
ferent biological actions  (for reviews, see references  19 and 
20).  The  function  of STAT  proteins  and  the  mechanism 
through  which  specificity  is  reached  in  each  particular 
cytokine-signaling  system  have  not  yet  been  clarified. 
However,  there  is  growing  evidence  that  STAT  proteins 
are likely to play an important role in mitogenesis, survival, 
or differentiation.  Therefore,  it would  not  be surprising  if 
JAK or STAT  proteins  are involved in  malignant  transfor- 
mation.  Recently,  this  hypothesis  has  been  supported  by 
two  studies  that  report  constitutive  activation  of  STAT 
proteins  in transformed  cells (45,  46),  suggesting that aber- 
rant  STAT  phosphorylation  in  response  to  oncogenic  ty- 
rosine kinases could contribute  to malignant cell growth. 
Although  Bcr/Abl was one of the first human  oncogenes 
described  to encode  a tyrosine kinase  (3),  its mechanisna  of 
816  Bcr/Abl Activates STAT Proteins Figure 7.  EMSA. Nuclear extracts from 32D cells, unstimulated (A and B, lanes 1) and IL-3 stimulated (A and B, lanes 2), 32Dp210 (A and B, lanes 3). 
K562 (A and B, lanes 4), BVI73 (A and B, lanes 5), and U937 (A and B, lanes 6) cells were incubated with -s2P-labeled probe and analyzed  by electro- 
phoresis. (A) Antibodies  against STAT1 were included in the binding incubation in lanes 7-12. (13) Antibodies against STATS were included in the bind- 
ing incubation in lanes 7-12. 
transformatien  is  still  poorly  understood.  The p210BCR/ 
ABL  oncogene  is  expressed  in  hematopoietic  stem  cells, 
and causes massive expansion of progenitor cell pools, par- 
ticularly  in  the  blood  and  spleen  (47,  48),  Differentiation 
along the granulocytic pathway may be enhanced, whereas 
there is litde  or no augmentation  of erythropoiesis or lym- 
phopoiesis  in  most patients.  In  some  patients,  there  is  in- 
creased  production  or  accumulation  of basophils,  eosino- 
phils,  or platelets.  These  apparent  lineage-restricted  effects 
of a stem  cell oncogene are so far unexplained.  When pri- 
mary cells are analyzed in vitro, their phenotype is also sub- 
tle, mainly characterized by a decreased susceptibility to ap- 
optosis  and  adhesion  defects  (38,  41,  49).  In experimental 
models,  in  contrast  to  the  human  disease,  p210Bcr/Abl  is 
associated  with  a  block  in  hematopoietic  differentiation 
and/or acquisition of factor independence  (6-9). 
In  this  study,  we  show  that  STAT1  and  STAT5,  or 
closely  related  proteins,  are  persistently  phosphorylated  in 
cell lines transformed by Bcr/Abl, whereas STAT3, STAT4, 
and  STAT6  are  not.  These  results  are  of interest  because 
STAT5, and to a lesser extent STAT1, are transiently phos- 
phorylated on tyrosine residues in factor-dependent cells  in 
response to cytokines such  as IL-3 and  GM-CSF  (25,  27). 
Thus,  STAT phosphorylation  may represent  an  important 
point of convergence between the Bcr/Abl and IL-3/GM- 
CSF signaling pathways that could contribute to the known 
overlap in the biological effects of IL-3 and Bcr/Abl. 
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To  understand  the  potential  significance  of Bcr/Abl- 
induced  tyrosine  phosphorylation  of STAT  proteins,  we 
first asked if this phenomenon was direcdy due to Bcr/Abt 
tyrosine kinase  activity.  Cell  lines transformed by Bcr/Abl 
tend  to  accumulate  cellular  mutations  (50),  and  some 
events observed in cultured cell hnes are hkely to be due to 
secondarily acquired genetic alterations.  In an effort to de- 
fine  the  primary  consequences  of Bcr/Abl  kinase  activity 
and  to  distinguish  these  from  secondary  events  associated 
with  transformation,  we developed  a  system in which  the 
tyrosine  kinase  activity of p210Bcr/Abl  could  be  induced 
by temperature  shift  and  the  direct  effects of Bcr/Abl  ex- 
pression  observed  in  the  IL-3-dependent  hematopoietic 
routine  cell hne 32D  (38).  In the present  study,  we found 
that the tyrosine phosphorylation of STAT proteins was di- 
rectly dependent  on the level of tyrosine kinase activity of 
Bcr/Abl.  This  result  suggests  that  the  increased  tyrosine 
phosphorylation of STAT proteins in Bcr/Abl-transformed 
cell lines is due directly to Bcr/Abl and not to a secondary 
mutation.  Furthermore,  these  results  indicate  that  STAT 
phosphorylation  is  not sufficient  for cell  proliferation,  but 
could be  involved  in  other events  such  as  prolonged  sur- 
vival. 
A  critical  question  in these  studies  is whether  Bcr/Abl- 
mediated tyrosyl phosphorylation of STAT proteins occurs 
on specific tyrosine residues  that are important for the for- 
mation  of  STAT-containing  DNA-binding  complexes. This issue  was examined in two ways. First,  STAT tyrosyl 
phosphorylation  was  surveyed in  CML  cell  lines  using  a 
previously described antibody that recognizes STAT1 phos- 
phorylated at tyrosine residue 701  (39).  Phosphorylation of 
Y701  has  been  shown  to  be  critical  for translocation  of 
STAT1  to  the  nucleus  and for subsequent  transcriptional 
activation  (23).  The  antibody  also  reacts  with  phospho- 
STAT5, but not with any STAT protein in quiescent he- 
matopoietic cells  (Frank, D.A., unpublished observations). 
The  reactivity  of the  phospho-STAT  antibody  with  the 
STAT  proteins  in  cells  transformed  by Bcr/Abl  suggests 
that these STAT proteins are likely to be phosphorylated in 
response  to  Bcr/Abl  at  a  biologically  important  tyrosine 
residue.  It is  interesting  that  the  SDS-PAGE  mobility of 
STAT proteins detected by this antibody in Bcr/Abl-trans- 
formed cell lines was similar but not identical to the mobil- 
ity of STAT proteins detected in nontransformed cells after 
IL-3 stimulation. 
A  second  observation,  which  supports  the  notion  that 
Bcr/Abl-induced  STAT  protein  phosphorylation  takes 
place on biologically important tyrosine residues, is the de- 
tection  of STAT-containing  DNA-binding  complexes in 
Bcr/Abl-transformed cell lines.  Using gel shift assays with 
an IILF-1 promoter sequence that  can bind  STATI-con- 
taining protein complexes, we readily detected DNA-pro- 
tein complexes that could be supershifted with antibodies 
directed  against STAT1  and  STAT5.  It is interesting that 
these  complexes were  distinct  from  those  observed  after 
IL-3 stimulation in the same cell line. Overall, these results 
suggest that the observed tyrosyl phosphorylation of STAT 
proteins in Bcr/Abl-transformed cells is associated with the 
formation of DNA-binding  complexes that  have  the  po- 
tential to affect gene transcription. We also detected com- 
plexes in 32Dp210Bcr/Abl  and in BV173  cells  that could 
not be supershifted with anti-STAT1 or anti-STATS anti- 
bodies, suggesting that either as yet unidentified STAT re- 
lated proteins or non-STAT proteins participate in the for- 
mation of the DNA-binding complex. It is interesting that 
we  observed  heterogeneity  in  DNA-complex  formation 
among Bcr/Abl-transformed cell lines.  This could be due 
to  species or cell  lineage  differences in  the  availability of 
STATs and other proteins. 
The mechanism of increased tyrosine phosphorylation of 
STAT proteins in response to Bcr/Abl is not yet known. It 
is possible that Bcr/Abl activates a JAK family kinase or a 
cytokine receptor.  We did not observe any consistent in- 
creases in  tyrosyl phosphorylation  ofJAK1, JAK2, JAK3, 
and Tyk2. However, tyrosine phosphorylation of Tyk2 in 
K562  cells  and JAK1  in  BV173  cells  was  increased  over 
background  levels,  raising  the  possibility  that  these JAKs 
may  contribute  to  STAT  phosphorylation  in  these  cell 
lines. It is also possible that Bcr/Abl activates one or more 
cytokine receptors, and studies to directly assess this possi- 
bility are warranted. An equally attractive hypothesis is that 
STAT proteins are phosphorylated directly by Bcr/Abl,  as 
may be the case for v-src (46).  In fact, STAT proteins con- 
tain SH2 domains (51),  and since Bcr/Abl is heavily phos- 
phorylated on tyrosine  residues,  it is possible that  one  or 
more  STAT  proteins  bind  to  Bcr/Abl  directly  through 
their SH2 domains. Although we were not able to copre- 
cipitate Bcr/Abl and any STAT protein  (our unpublished 
observations), STAT proteins may be substrates of Bcr/Abl 
without  physically binding  or only transiently  binding  to 
the kinase. A third possibility is that increased STAT phos- 
phorylation is due primarily to inhibition  of one or more 
tyrosine phosphatases. There is good evidence that Bcr/Abl 
interacts  with  at  least  two  phosphatases,  SHPTP2  (Syp, 
PTP1C)  and SHPTP1  (HCP)  (18).  At the present time, it 
is not known if the association of Bcr/Abl with either one 
of these enzymes affects its phosphatase activity. 
Increased STAT phosphorylation is not a general prop- 
erty of leukemic transformation. Several other myeloid and 
lymphoid leukemia cell lines that do not express Bcr/Abl 
(U937, HL-60, ILL, NALM6) have been analyzed, and no 
increased  tyrosine phosphorylation of STAT proteins was 
observed.  Overall,  our results suggest a  novel mechanism 
contributing to transformation by a human oncogene. We 
suggest that some of the unique effects of Bcr/Abl on mye- 
loid lineage cells, such as enhanced basophil differentiation, 
are particularly likely to be due to STAT activation. 
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